Boehringer Loses Bid To Decertify Sales Rep OT Action

Law360, San Diego (November 30, 2011, 8:06 PM EST) -- A Connecticut federal judge on Tuesday declined Boehringer Ingelheim Pharmaceuticals Inc.’s attempt to decertify a collective action alleging the drugmaker failed to properly compensate its drug sales representatives for overtime.

Boehringer argued in its motion that the class should be decertified because the representatives fell short of establishing any common nucleus of operative facts binding together the class, but U.S. District Judge Janet Bond Arterton issued an oral ruling shooting down the company’s bid, and the court on Wednesday set trial for June 2012.

“We’re pleased...
To view the full article, register now.